Impax Laboratories Inc. (IPXL) Tops Q2 EPS by 16c
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Financial Fact:
Research and development: 20.12M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 20.12M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Impax Laboratories Inc. (NASDAQ: IPXL) reported Q2 EPS of $0.60, $0.16 better than the analyst estimate of $0.44. Revenue for the quarter came in at $166.5 million versus the consensus estimate of $162.03 million.
For earnings history and earnings-related data on Impax Laboratories Inc. (IPXL) click here.
For earnings history and earnings-related data on Impax Laboratories Inc. (IPXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- BofA says momentum style supported by earnings revisions
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
